Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.526 USD | -10.22% | +15.09% | -75.83% |
03/06 | Aethlon Medical, Inc. Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies | CI |
15/05 | Top Midday Decliners | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-75.83% | 54.08L | |
+8.81% | 22TCr | |
+13.56% | 19TCr | |
+23.53% | 15TCr | |
+32.97% | 11TCr | |
+4.18% | 6.65TCr | |
+12.49% | 5.31TCr | |
+3.16% | 5TCr | |
-4.73% | 3.88TCr | |
-2.57% | 3.48TCr |
- Stock Market
- Equities
- AEMD Stock
- News Aethlon Medical, Inc.
- Transcript : Aethlon Medical, Inc., Q2 2022 Earnings Call, Nov 09, 2021